Moderna

A panel of CDC advisers voted Tuesday to recommend updated Pfizer and Moderna coronavirus booster shots for everyone ages 6 months and up.

Moderna’s chief medical officer said advancements in mRNA technology since the outset of the Covid pandemic have ushered in a golden age for new vaccines. 

The patent infringement lawsuits were filed in the U.S. District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany, according to a news release.

Moderna sued Pfizer and its German partner BioNTech on Friday, alleging that the two companies copied Moderna’s technology in developing their COVID-19 vaccine Comirnaty. Moderna said in a news release that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 covering its mRNA technology, which Moderna used to develop its own COVID-19 vaccine, Spikevax.

Moderna said Tuesday it had asked the Food and Drug Administration to authorize an updated version of its Covid booster shot.

The Biden administration says it has reached an agreement with Moderna to buy 66 million doses of the company’s next generation of COVID-19 vaccine targeting the highly transmissible omicron variant.

The Pfizer and Moderna shots are now available at local pharmacies around LA County — but just because they’re available doesn’t mean parents are rushing to get their kids vaccinated. Toni Guinyard reports for Today in LA on Tuesday, June 21, 2022. 

Pfizer-BioNTech and Moderna vaccines are safe and effective for children 6 months old and up, clearing the way for its use in California, Nevada, Oregon and Washington, the Western States Scientific Safety Review Workgroup announced Sunday afternoon.

The FDA must still decide whether to take the recommendations and approve the COVID-19 vaccine for kids between six months and 5 years old.

COVID-19 shots for U.S. infants, toddlers and preschoolers moved a step closer Wednesday.

A government advisory panel has endorsed a second brand of COVID-19 vaccine for school-age children and teens. The expert panel agreed Tuesday that the vaccine made by Moderna is safe and effective enough to give to U.S. kids ages 6 to 17. A vaccine made by Pfizer has been available since last year for those ages. The Food and Drug...

Moderna submitted data to the Food and Drug Administration that it hopes will prove two low-dose shots can protect children under the age of 6.

Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.

A 50-microgram dose of Moderna’s new vaccine doubled the antibodies against the omicron variant six months after administration.